• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • A. Jonas Ekstrand, C. David James, Webster K Cavenee, Barbara Seliger, R. F. A. Pettersson, Vincent Peter Collins
  • Biology, Medicine
  • Cancer research
  • 1991 (First Publication: 15 April 1991)
  • Anomalies of the epidermal growth factor receptor (EGFR) gene, including amplification, rearrangement, and overexpression, have been reported in malignant human gliomas in vivo. In vitro glioma cellExpand
  • P Avirutnan, Prida Malasit, Barbara Seliger, Sucharit Bhakdi, Marc J. Husmann
  • Biology, Medicine
  • Journal of immunology
  • 1998 (First Publication: 1 December 1998)
  • Dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS) are severe complications of secondary dengue virus (DV) infection. Vascular leakage, hemorrhagic diathesis and complement activation areExpand
  • Yumeng Mao, Dhifaf Sarhan, André Steven, Barbara Seliger, Rolf Kiessling, Andreas Lundqvist
  • Biology, Medicine
  • Clinical Cancer Research
  • 2014 (First Publication: 6 June 2014)
  • Purpose: Increased frequencies of myeloid-derived suppressor cells (MDSC) correlate with poor prognosis in patients with cancers. Tumor-derived prostaglandin-E2 (PGE2) plays an important role inExpand
  • Markus Meissner, Torsten Eugen Reichert, +4 authors Barbara Seliger
  • Medicine, Biology
  • Clinical Cancer Research
  • 2005 (First Publication: 1 April 2005)
  • Purpose: Human leukocyte antigen (HLA) class I antigen defects, which are frequently present in head and neck squamous cell carcinoma (HNSCC) cells may provide the tumor with an escape mechanism fromExpand
  • Andreas A. Hombach, D Sent, +5 authors Hinrich Abken
  • Biology, Medicine
  • Cancer research
  • 2001 (First Publication: 3 March 2001)
  • Recombinant T-cell receptors with antibody-like specificity are successfully used to direct CTLs toward a MHC-independent immune response against target cells. Here we monitored the specificExpand